Outcomes and Benefits of Using Twice Daily Nebulised Hypertonic Saline in T2-Low and T2-High Asthma With Bronchial Hypersecretion: A Retrospective Cohort Study
Cureus reported this story. We're following it; read the full report below.
More in Health
- Assam to establish India's first state-run proton therapy centre in Guwahati
- Denosumab Duration Linked to Jaw Necrosis Risk in Prostate Cancer
- Odisha Leads Nation in AB PM-JAY Card Distribution & Health Claims Settlement
- The growing burden of diabetes mellitus in Ethiopia: a systematic review and meta-analysis
- Older Adults With Sarcopenia May Be Losing Muscle Unevenly
- SGLT2 Inhibitors Linked to Higher Haemoglobin and Haematocrit